NO20050786L - Isosorbidmononitratblandinger og fremgangsmater for deres anvendelse - Google Patents
Isosorbidmononitratblandinger og fremgangsmater for deres anvendelseInfo
- Publication number
- NO20050786L NO20050786L NO20050786A NO20050786A NO20050786L NO 20050786 L NO20050786 L NO 20050786L NO 20050786 A NO20050786 A NO 20050786A NO 20050786 A NO20050786 A NO 20050786A NO 20050786 L NO20050786 L NO 20050786L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- ismns
- ismn
- reduction
- therapeutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/214,345 US20040029959A1 (en) | 2002-08-08 | 2002-08-08 | Isosorbide mononitrate compositions and methods of their use |
PCT/IB2003/004245 WO2004014849A2 (fr) | 2002-08-08 | 2003-08-08 | Compositions de mononitrate d'isosorbide et procedes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050786L true NO20050786L (no) | 2005-05-03 |
Family
ID=31494642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050786A NO20050786L (no) | 2002-08-08 | 2005-02-14 | Isosorbidmononitratblandinger og fremgangsmater for deres anvendelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040029959A1 (fr) |
EP (1) | EP1545550A4 (fr) |
JP (1) | JP2005535700A (fr) |
AU (1) | AU2003263515A1 (fr) |
CA (1) | CA2495071A1 (fr) |
IL (1) | IL166299A0 (fr) |
MX (1) | MXPA05001559A (fr) |
NO (1) | NO20050786L (fr) |
PL (1) | PL375274A1 (fr) |
WO (1) | WO2004014849A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106093247A (zh) * | 2016-08-19 | 2016-11-09 | 蚌埠丰原涂山制药有限公司 | 一种检测单硝酸异山梨酯中乙酸乙酯残留量的方法 |
CN107582540B (zh) * | 2017-09-19 | 2018-06-05 | 扬子江药业集团上海海尼药业有限公司 | 一种单硝酸异山梨酯胶囊及其制备方法 |
CN107802610B (zh) * | 2017-11-22 | 2020-10-20 | 乐普药业股份有限公司 | 一种单硝酸异山梨酯缓释片及制备方法 |
CN112121025B (zh) * | 2019-06-24 | 2022-05-31 | 翰宇药业(武汉)有限公司 | 一种单硝酸异山梨酯缓释片剂及其制备方法 |
CN110478328A (zh) * | 2019-08-15 | 2019-11-22 | 仁和堂药业有限公司 | 单硝酸异山梨酯片的制备工艺 |
CN110559269A (zh) * | 2019-08-15 | 2019-12-13 | 仁和堂药业有限公司 | 一种单硝酸异山梨酯片剂及其质量检测方法 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000254A (en) * | 1966-04-25 | 1976-12-28 | Schmid Laboratories, Inc. | Fungimycin compositions |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
JPS578490Y2 (fr) * | 1977-08-12 | 1982-02-18 | ||
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
CH647676A5 (fr) * | 1978-12-22 | 1985-02-15 | Donald E Panoz | Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation. |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4336243A (en) * | 1980-08-11 | 1982-06-22 | G. D. Searle & Co. | Transdermal nitroglycerin pad |
JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4557925A (en) * | 1982-07-08 | 1985-12-10 | Ab Ferrosan | Membrane-coated sustained-release tablets and method |
US4634587A (en) * | 1982-07-09 | 1987-01-06 | Key Pharmaceuticals, Inc. | Sustained release quinidine dosage form |
IE53703B1 (en) * | 1982-12-13 | 1989-01-18 | Elan Corp Plc | Drug delivery device |
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
FR2542998B1 (fr) * | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
DE3333639A1 (de) * | 1983-09-17 | 1985-03-28 | Dynamit Nobel Ag | Zubereitung von nitroestern fuer die koronartherapie |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
DE3406497A1 (de) * | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung |
CH658188A5 (de) * | 1984-03-23 | 1986-10-31 | Ciba Geigy Ag | Lagerstabile schnellzerfallende pharmazeutische presslinge. |
CA1248450A (fr) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Piece molle |
JPS6124516A (ja) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4767808A (en) * | 1984-10-05 | 1988-08-30 | Hercon Laboratories Corporation | Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant |
US4681584A (en) * | 1985-05-03 | 1987-07-21 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
US4615699A (en) * | 1985-05-03 | 1986-10-07 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
US4655766A (en) * | 1985-08-01 | 1987-04-07 | Alza Corporation | Fluid imbibing pump with self-regulating skin patch |
US4698062A (en) * | 1985-10-30 | 1987-10-06 | Alza Corporation | Medical device for pulsatile transdermal delivery of biologically active agents |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5141752A (en) * | 1986-05-09 | 1992-08-25 | Alza Corporation | Delayed drug delivery device |
ES2028074T3 (es) * | 1986-06-13 | 1992-07-01 | Alza Corporation | Activacion por humedad de un sistema de suministro transdermico de farmacos. |
IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
ATE71293T1 (de) * | 1986-09-18 | 1992-01-15 | London Pharmacy Innovation | Arzneiformulierung. |
CH672888A5 (fr) * | 1986-11-07 | 1990-01-15 | Mepha Ag | |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
US5071656A (en) * | 1987-03-05 | 1991-12-10 | Alza Corporation | Delayed onset transdermal delivery device |
US4956181A (en) * | 1987-05-08 | 1990-09-11 | Eastman Kodak | Nitrate therapy for angina pectoris |
EP0290262A3 (fr) * | 1987-05-08 | 1990-12-12 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Thérapie de l'angine de poitrine par le nitrate |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
IE64726B1 (en) * | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
US4971805A (en) * | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
DE4031881C2 (de) * | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung |
KR100354702B1 (ko) * | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
US5458887A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
JPH11501026A (ja) * | 1995-02-28 | 1999-01-26 | アストラ・アクチエボラーグ | イソソルビド−5−モノナイトレートの使用 |
WO1998027967A1 (fr) * | 1996-12-20 | 1998-07-02 | Dumex-Alpharma A/S | Comprimes enrobes a liberation controlee |
US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US5851555A (en) * | 1997-08-15 | 1998-12-22 | Fuisz Technologies Ltd. | Controlled release dosage forms containing water soluble drugs |
US6372254B1 (en) * | 1998-04-02 | 2002-04-16 | Impax Pharmaceuticals Inc. | Press coated, pulsatile drug delivery system suitable for oral administration |
BR9905261A (pt) * | 1999-09-30 | 2001-07-24 | Libbs Farmaceutica Ltda | Uma nova associação medicamentosa de liberação programada |
US7108866B1 (en) * | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
JP4696210B2 (ja) * | 2000-06-07 | 2011-06-08 | トーアエイヨー株式会社 | イソソルビド‐5‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法 |
-
2002
- 2002-08-08 US US10/214,345 patent/US20040029959A1/en not_active Abandoned
-
2003
- 2003-08-08 AU AU2003263515A patent/AU2003263515A1/en not_active Abandoned
- 2003-08-08 MX MXPA05001559A patent/MXPA05001559A/es unknown
- 2003-08-08 JP JP2004527255A patent/JP2005535700A/ja active Pending
- 2003-08-08 EP EP03784442A patent/EP1545550A4/fr not_active Withdrawn
- 2003-08-08 WO PCT/IB2003/004245 patent/WO2004014849A2/fr active Application Filing
- 2003-08-08 PL PL03375274A patent/PL375274A1/xx unknown
- 2003-08-08 CA CA002495071A patent/CA2495071A1/fr not_active Abandoned
-
2005
- 2005-01-13 IL IL16629905A patent/IL166299A0/xx unknown
- 2005-02-14 NO NO20050786A patent/NO20050786L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL166299A0 (en) | 2006-01-15 |
MXPA05001559A (es) | 2005-08-19 |
EP1545550A4 (fr) | 2011-04-13 |
JP2005535700A (ja) | 2005-11-24 |
CA2495071A1 (fr) | 2004-02-19 |
US20040029959A1 (en) | 2004-02-12 |
WO2004014849A3 (fr) | 2004-11-11 |
WO2004014849A2 (fr) | 2004-02-19 |
EP1545550A2 (fr) | 2005-06-29 |
PL375274A1 (en) | 2005-11-28 |
AU2003263515A1 (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050786L (no) | Isosorbidmononitratblandinger og fremgangsmater for deres anvendelse | |
TW283645B (fr) | ||
NO953093D0 (no) | Forbindelser med både sterk kalsiumantagonist- og antioksidantvirkning, samt anvendelse derav som cellebeskyttende midler | |
PT1066052E (pt) | Celulas estaminais mesenquimatosas para a prevencao e tratamento | |
WO2004078113A3 (fr) | Traitement et prevention de l'obesite au moyen d'inhibiteurs de cox-2 seul ou en combinaison avec des agents d'amaigrissement | |
WO2005037323A3 (fr) | Methode pour inhiber une signalisation de nf-kappa b et son utilisation pour traiter et pour prevenir des maladies humaines | |
WO2000040235A3 (fr) | Traitement de l'asthme a l'aide d'inhibiteurs de mek | |
WO2005107793A3 (fr) | Ngal pour la reduction et l'amelioration des lesions ischemiques et nephrotoxiques | |
IL158559A0 (en) | Acne treatment | |
NO20051426L (no) | Behandling av melanom ved reduksjon i clusterin-nivaer | |
WO2005044194A3 (fr) | Traitement ou prevention de la neoplasie a l'aide d'un inhibiteur de la proteine hsp90 | |
BG106461A (en) | Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction | |
WO2003018061A1 (fr) | Medicaments contenant un inhibiteur de la chymase et un inhibiteur de l'ace comme principes actifs | |
WO2004043456A8 (fr) | Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination | |
DK1429756T3 (da) | Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer | |
WO2004000227A3 (fr) | Utilisation de derives de thio-oxindole dans le traitement de troubles cutanes | |
HK1099918A1 (en) | Composition and use for prevention or treatment of stomatitis | |
WO2002056837A3 (fr) | Inhibition de proteines phosphatases dans le traitement de l'insuffisance cardiaque | |
WO2002028433A3 (fr) | Medicaments | |
BR0308396A (pt) | Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus | |
EP1610814B8 (fr) | Compositions therapeutiques pour pathologies auto-immunes | |
BR0113886A (pt) | Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit | |
MXPA05012696A (es) | Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica. | |
WO1996000068A3 (fr) | Therapie combinee contre les infections a vih | |
WO2004012732A3 (fr) | Utilisation d'un inhibiteur du proteasome dans le traitement du dysfonctionnement endothelial et/ou dans le cadre d'une therapie a base de proteasome a faible dose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |